Literature DB >> 29396844

Evaluation of Probiotic Potential of Bacteriocinogenic Lactic Acid Bacteria Strains Isolated from Meat Products.

Izildinha Moreno1, Elza Teresinha Grael Marasca1, Patrícia Blumer Zacarchenco Rodrigues de Sá1, Josiane de Souza Moitinho1, Miriam Gonçalves Marquezini1, Márcia Regina Cucatti Alves1, Renata Bromberg2.   

Abstract

In this study, the probiotic potential of five bacteriocin-producing lactic acid bacteria (LAB) strains, isolated from meat products, was investigated. They were presumptively identified as Lactococcus lactis subsp. cremoris CTC 204 and CTC 483, L. lactis subsp. hordinae CTC 484, and Lactobacillus plantarum CTC 368 and CTC 469 according to morphological, biochemical, and physiological characteristics. Analysis of genetic variability (random amplified polymorphic (RAPD)-PCR) and whole-cell proteins (SDS-PAGE) revealed similarity between Lactobacillus strains and variability among Lactococcus strains. The evaluation of the probiotic potential showed that the five LAB strains were tolerant to pH 2.0, and only strain CTC 469 was tolerant to the lowest concentration of the bile salts evaluated (0.1%). All strains showed survival or growth ability at 4, 25, and 37 °C, and tolerance at - 20 °C. Although strain CTC 204 in TSB Broth supplemented with MgSO4 showed the highest intensity of biofilm production, this compound was produced by all of them. The safety assessment showed that no thermonuclease, hemolytic, or gelatinase activities were detected. All strains were resistant to erythromycin and sensitive to amoxicillin and phenoxymethylpenicillin; furthermore, CTC 204 was resistant to chloramphenicol, CTC 368 and CTC 469 to chloramphenicol and vancomycin, CTC 483 to tetracycline and vancomycin, and CTC 484 to clindamycin and chloramphenicol. The evaluated strains showed biogenic amine production; the lowest levels were produced by CTC 204 and CTC 368 strains. It was concluded that CTC 204 and CTC 368 strains have the greatest potential for becoming probiotics.

Entities:  

Keywords:  Bacteriocin; Biofilm; Lactic acid bacteria; Meat; Probiotic; Safety

Mesh:

Substances:

Year:  2018        PMID: 29396844     DOI: 10.1007/s12602-018-9388-9

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  34 in total

Review 1.  Safety of probiotics that contain lactobacilli or bifidobacteria.

Authors:  S P Borriello; W P Hammes; W Holzapfel; P Marteau; J Schrezenmeir; M Vaara; V Valtonen
Journal:  Clin Infect Dis       Date:  2003-03-05       Impact factor: 9.079

Review 2.  Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora.

Authors:  V Redondo-Lopez; R L Cook; J D Sobel
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

3.  Application of in vitro methods for selection of Lactobacillus casei strains as potential probiotics.

Authors:  Vijendra Mishra; D N Prasad
Journal:  Int J Food Microbiol       Date:  2005-08-15       Impact factor: 5.277

Review 4.  Probiotics, gut microbiota and health.

Authors:  M-J Butel
Journal:  Med Mal Infect       Date:  2013-11-28       Impact factor: 2.152

Review 5.  Ten years of subproteome investigations in lactic acid bacteria: A key for food starter and probiotic typing.

Authors:  E Mangiapane; R Mazzoli; A Pessione; B Svensson; K Riedel; E Pessione
Journal:  J Proteomics       Date:  2015-05-06       Impact factor: 4.044

6.  Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

Authors:  Colin Hill; Francisco Guarner; Gregor Reid; Glenn R Gibson; Daniel J Merenstein; Bruno Pot; Lorenzo Morelli; Roberto Berni Canani; Harry J Flint; Seppo Salminen; Philip C Calder; Mary Ellen Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-06-10       Impact factor: 46.802

7.  Safety properties and molecular strain typing of lactic acid bacteria from slightly fermented sausages.

Authors:  T Aymerich; B Martín; M Garriga; M C Vidal-Carou; S Bover-Cid; M Hugas
Journal:  J Appl Microbiol       Date:  2006       Impact factor: 3.772

Review 8.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

9.  Lactose digestion by yogurt beta-galactosidase: influence of pH and microbial cell integrity.

Authors:  M C Martini; G L Bollweg; M D Levitt; D A Savaiano
Journal:  Am J Clin Nutr       Date:  1987-02       Impact factor: 7.045

10.  Probiotic encapsulation technology: from microencapsulation to release into the gut.

Authors:  Gildas K Gbassi; Thierry Vandamme
Journal:  Pharmaceutics       Date:  2012-02-06       Impact factor: 6.321

View more
  4 in total

1.  Comparative Analysis of Inhibition-Based and Indicator-Independent Colorimetric Assay for Screening of Bacteriocin-Producing Lactic Acid Bacteria.

Authors:  Manoj Kumar Yadav; Bijender Singh; Santosh Kumar Tiwari
Journal:  Probiotics Antimicrob Proteins       Date:  2019-06       Impact factor: 4.609

2.  In vitro evaluation of probiotic properties of lactic acid bacteria isolated from the vagina of yak (Bos grunniens).

Authors:  Qingli Zhang; Yangyang Pan; Meng Wang; Liang Sun; Yao Xi; Mei Li; Qiaoying Zeng
Journal:  PeerJ       Date:  2022-03-29       Impact factor: 2.984

Review 3.  Research Update on the Impact of Lactic Acid Bacteria on the Substance Metabolism, Flavor, and Quality Characteristics of Fermented Meat Products.

Authors:  Yi Wang; Jun Han; Daixun Wang; Fang Gao; Kaiping Zhang; Jianjun Tian; Ye Jin
Journal:  Foods       Date:  2022-07-14

4.  In vitro investigation on lactic acid bacteria isolatedfrom Yak faeces for potential probiotics.

Authors:  Qingli Zhang; Meng Wang; Xin Ma; Zhijie Li; Chenghui Jiang; Yangyang Pan; Qiaoying Zeng
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.